TP53 and hepatocellular carcinoma: However, in the present meta-analysis, we found that TP53 R72P polymorphism was not significantly associated with the risk of HCC neither in the overall combined analysis nor the stratified analyses according to ethnicity and hepatitis virus infection status, which was inconsistent with the previous meta-analysis conducted by Lv et al. [17] and Ding et al. [18].